AHR and chronic kidney disease: Therefore, even though other authors reported the efficacy of AhR inhibition in contrasting RAS activation due to IS in CKD,39 our data indicate that this strategy may not be the optimal one to antagonize the actions of IS on cFib and, indirectly, on nm‐cardiomyocytes.